Dagny Stuart

A Nashville-based dietitian who lost her mother to cancer is using the power of social media to raise funds for chemo care bags for cancer patients. Read More

Lauren Hackett, MPA, executive director of Administration at Vanderbilt-Ingram Cancer Center (VICC) and chief business officer for Oncology, Imaging and Quantitative Sciences Administration, has been chosen as one of the 2015 Women to Watch by Nashville Medical News. Read More

Efforts to enable the immune system to “see” the cancer and attack the aberrant cells were the prime focus during Vanderbilt-Ingram Cancer Center’s Annual Retreat, held April 30 at the Vanderbilt University Student Life Center. Read More

Valerie Malyvanh Jansen, M.D., Ph.D., a third-year medical oncology fellow, recently received several national awards and grants, as well as a Vanderbilt-Ingram Cancer Center fellowship, in recognition of her translational cancer research. Read More

Adding an investigational drug to an already approved estrogen blocking therapy appears to be safe and provided clinical benefit for some postmenopausal women with estrogen-positive breast cancer. Read More

Vanderbilt University Medical Center physicians recently provided free cancer screenings for 116 patients at the Odess Head and Neck Cancer Surgery Clinic and the Veterans Affairs Tennessee Valley Healthcare System. Read More

The Vanderbilt-Ingram Cancer Center (VICC) at Franklin has added new technology to enhance treatment for patients needing radiation therapy or stereotactic body radiation. Read More

A new study led by Vanderbilt University investigators found that patients being treated with statins at the time of surgery for kidney cancer, also known as renal cell carcinoma, had improved overall survival and disease-specific survival. Read More

Vanderbilt’s Department of Otolaryngology-Head and Neck Surgery and Vanderbilt-Ingram Cancer Center are providing free head and neck cancer screenings Friday, April 17. The screenings are open to the public and no appointments are needed. Read More

Of every 100 people in the United States, at least three men or women will be diagnosed with head and neck cancer in their lifetimes. These cancers can occur in the nasal cavity, sinuses, throat, lips, mouth, thyroid, salivary glands or the voice box (larynx). Read More

The death rates for most forms of cancer continue to decline at a modest pace among men, women and children in the United States, according to the Annual Report to the Nation on the Status of Cancer 1975 – 2011. Read More

Vanderbilt-Ingram Cancer Center investigators have identified the mechanisms used by a gene and its binding protein to drive tumor growth in several forms of cancer, including non-small cell lung cancer. Read More

Douglas Johnson, M.D. Douglas Johnson, M.D., assistant professor of Medicine, has been named a recipient of the National Comprehensive Cancer Network (NCCN) Foundation Young Investigator Awards. The two-year grant will provide $150,000 in funding for his research on survivorship among cancer patients who receive drugs… Read More

Vanderbilt-Ingram Cancer Center, along with Nashville Public Television (NPT), the American Cancer Society and Gilda’s Club Nashville, will sponsor a special community event to preview an upcoming PBS television documentary on cancer. Read More

Melanoma patients whose tumors test positive for mutations in the NRAS gene were more likely to benefit from new immunotherapy drugs, according to a new study led by Vanderbilt-Ingram Cancer Center (VICC) investigators. Read More

Vanderbilt-Ingram Cancer Center’s Michael Savona, associate professor of medicine and director of the Hematology Early Therapeutics Program, will headline a seminar on new therapies and treatment options for patients with myelodysplastic syndrome. Read More

Two Vanderbilt-Ingram Cancer Center (VICC) leaders have been named to a panel of the Institute of Medicine (IOM) to help shape national policies on the use of biomarkers for targeted cancer therapies. Read More

Improvements in cancer diagnosis and treatment have led to longer survival for most cancer patients in the United States. However, the improvement in survival was substantially greater among younger patients and those who are white in most of the cancers studied, according to new research by Vanderbilt University investigators. Read More

Carlos L. Arteaga, M.D., director of the Center for Cancer Targeted Therapies and director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), has been named a fellow of the AACR Academy. Read More

Country music group BlackHawk recently presented a check for $20,000 to Harold (Hal) Moses, M.D., Ingram Professor of Cancer Research and director emeritus of Vanderbilt-Ingram Cancer Center (VICC), in support of cancer research. Read More